ArticleInfectious diseases and therapy2026

A Phase 2 Trial Evaluating the Immunogenicity and Safety of an mRNA-Based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase.

Brian Moldt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.